Target intelligence / Profile preview

28S ribosomal RNA sarcin-ricin loop (SRL) (SRL)

Target
SRL
Molecular classification
Ribosomal RNA, RNA motif, Other
01

Overview

The 28S ribosomal RNA sarcin-ricin loop (SRL) is a highly conserved RNA structural motif located in the large subunit of the eukaryotic ribosome (Endo et al., 1982). It is essential for protein synthesis, acting as the critical docking site for translation elongation factors EF-1 and EF-2 (Grela et al., 2014). The loop facilitates the interaction between the ribosome and these factors, triggering the GTP hydrolysis required for the translocation of tRNA and mRNA (Clementi et al., 2010). The SRL is the specific molecular target for ribosome-inactivating proteins (RIPs), such as ricin from castor beans and Shiga toxins from certain bacteria (Endo et al., 1987). These toxins function as RNA N-glycosidases that remove a specific adenine residue (A4565 in humans) from the loop, or as endonucleases like alpha-sarcin that cleave the RNA backbone (Stirpe, 2004). Such modifications prevent the binding of elongation factors, leading to the immediate and irreversible cessation of translation (Endo et al., 1987). Because of its vital role, the SRL is a focal point in toxicology and the development of targeted cancer therapies (Stirpe, 2004). Therapeutic strategies often involve conjugating RIPs to monoclonal antibodies to create immunotoxins that selectively deliver the toxin to malignant cells (Stirpe, 2004). Understanding the SRL's structure and function is crucial for developing antidotes to RIP poisoning and improving the efficacy of toxin-based drugs (Grela et al., 2014).

Other names
Sarcin-ricin loopSRLAlpha-sarcin loopRicin loop28S rRNA SRL
02

Mechanism of action

Inhibition of translation elongation by preventing elongation factor binding through site-specific RNA modification (depurination or cleavage).

03

Biological functions

Protein synthesisTranslation elongationGTPase activationOther
04

Disease associations

CancerInfectionOther
05

Safety considerations

Extreme systemic toxicityVascular leak syndromeImmunogenicity
06

Interacting drugs

Ricin

5 more in the full profile.

07

Biomarkers

Depurinated 28S rRNAFragmented 28S rRNA

Beyond the preview

Go deeper on 28S ribosomal RNA sarcin-ricin loop (SRL) (SRL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 28S ribosomal RNA sarcin-ricin loop (SRL) (SRL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call